Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Drug Enforcement Administration

          - [OMB Number 1117-0037] 

# ACTION:

30-day notice of information collection under review.

## Prescription Drug Monitoring Program Questionnaire 

                    The Department of Justice (DOJ), Drug Enforcement Administration (DEA) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the                     **Federal Register**                     Volume 74, Number 8, page 1709, on, January 13, 2009, allowing for a 60 day comment period.                 

The purpose of this notice is to allow for an additional 30 days for public comment until April 20, 2009. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to (202) 395-5806. 

Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: 
      - Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;
      - Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;
      - Enhance the quality, utility, and clarity of the information to be collected; and
      - Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g. , permitting electronic submission of responses.                 

Overview of Information Collection 1117-0037: 

                    (1)                     *Type of Information Collection:*                     Extension of a currently approved collection.                 

                    (2)                     *Title of the Form/Collection:*                     Prescription Drug Monitoring Program Questionnaire.                 

                    (3)                     *Agency Form Number, if Any, and the Applicable Component of the Department of Justice Sponsoring the Collection:*                     Form Number: None. Office of Diversion Control, Drug Enforcement Administration, Department of Justice.                 

                    (4)                     *Affected public who will be asked or required to respond, as well as a brief abstract:*

*Primary:*                     States.                 

*Other:*                     None.                 

*Abstract:*                     This questionnaire permits the Drug Enforcement Administration to compile and evaluate information regarding the design, implementation and operation of State prescription monitoring programs. Such information allows DEA to assist states in the development of new programs designed to enhance the ability of both DEA and State authorities to prevent, detect, and investigate the diversion and abuse of controlled substances.                 

                    (5)                     *An Estimate of the Total Number of Respondents and the Amount of Time Estimated for an Average Respondent to Respond:*                     It is estimated that 51 persons complete the Prescription Monitoring Program Questionnaire electronically, at 5 hours per form, for an annual burden of 255 hours.                 

                    (6)                     *An Estimate of the Total Public Burden (in Hours) Associated With the Collection:*                     It is estimated that there are 255 burden hours associated with this collection.                 

If additional information is required contact: Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street NW., Washington, DC 20530. 

Dated: March 11, 2009. 

Lynn Bryant, 

Department Clearance Officer, United States Department of Justice. 

[FR Doc. E9-6054 Filed 3-19-09; 8:45 am] 

BILLING CODE 4410-09-P